April 3, 2025
8.37am Fisher & Paykel: health products manufacturing splits 45% Mexico and 55% New Zealand with 43% of revenue in latest half coming from US market.
8.38am Treasury Wine Estates: minimal impact given US division produced 35% of EBIT in latest half buy 85% of this is produced in the US and not subject to 10% tariff like the other $35m in sales from the latest half.
9.37am Cochlear: hearing implants have traditionally been exempt but we'll know if the 10% tariff applies when the US Customers and Border Protection Notice of Implementation is published in the next week.
9.58am Cettire: 41% of total sales are from European goods sold into US market. However, individual sales below $US800 will remain exempt and their average sale is $US514. Announcement failed to say what tariff was proposed by Trump. Didn't realise how much Europe dominates luxury goods manufacturing.
11.22am CSL: a skinny effort pointing out that "at this stage pharmaceutical products are not subject to reciprocal tariffs".
11.53am Breville: generates 45% of sales in the US and currently manufacturers 90% of its product in China but is looking to diversify in Mexico, Cambodia and Indonesia. No mention of manufacturing in the US.
April 4, 2025
7.31am Tourism Holdings Ltd: the Auckland-based company warned of lower sales and rentals of its tourism vehicles in the US.
9.29am Ansell: manufactures in 5 Asian countries and generates 43% of its revenue from the US. It has maintained guidance because it will pass on the tariffs and current on-shore US competition is "negligible". Stock fell 14% yesterday.
9.33am Mesoblast: updated that tariffs were unlikely to apply to its USD drug sales.
4.49pm ARB Corp: a bit of a nothing statement about exports from Thailand to the US.
Copyright © 2025 The Mayne Report. All rights reserved